TrialInflammopharmacology2024

Repurposing celecoxib as adjuvant therapy in patients with Parkinsonian disease: a new therapeutic dawn: randomized controlled pilot study.

Mohannad O Khrieba et al.PubMed ↗Publisher ↗

No numbers read from the abstract.